Spain · Delayed Price · Currency is EUR Arteche Lantegi Elkartea Statistics
Total Valuation
BME:ART has a market cap or net worth of EUR 1.92 billion. The enterprise value is 1.98 billion.
| Market Cap | 1.92B |
| Enterprise Value | 1.98B |
Important Dates
The next estimated earnings date is Monday, September 7, 2026.
| Earnings Date | Sep 7, 2026 |
| Ex-Dividend Date | May 8, 2026 |
Share Statistics
BME:ART has 57.04 million shares outstanding. The number of shares has decreased by -0.12% in one year.
| Current Share Class | 57.04M |
| Shares Outstanding | 57.04M |
| Shares Change (YoY) | -0.12% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 12.82% |
| Float | 8.29M |
Valuation Ratios
The trailing PE ratio is 41.91 and the forward PE ratio is 34.21.
| PE Ratio | 41.91 |
| Forward PE | 34.21 |
| PS Ratio | 3.72 |
| PB Ratio | 15.97 |
| P/TBV Ratio | 23.17 |
| P/FCF Ratio | 53.35 |
| P/OCF Ratio | 37.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.60, with an EV/FCF ratio of 54.98.
| EV / Earnings | 43.74 |
| EV / Sales | 3.83 |
| EV / EBITDA | 24.60 |
| EV / EBIT | 30.23 |
| EV / FCF | 54.98 |
Financial Position
The company has a current ratio of 1.21, with a Debt / Equity ratio of 1.19.
| Current Ratio | 1.21 |
| Quick Ratio | 0.85 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | 1.80 |
| Debt / FCF | 3.96 |
| Interest Coverage | 8.09 |
Financial Efficiency
Return on equity (ROE) is 46.26% and return on invested capital (ROIC) is 37.56%.
| Return on Equity (ROE) | 46.26% |
| Return on Assets (ROA) | 9.14% |
| Return on Invested Capital (ROIC) | 37.56% |
| Return on Capital Employed (ROCE) | 27.75% |
| Weighted Average Cost of Capital (WACC) | 7.10% |
| Revenue Per Employee | 275,140 |
| Profits Per Employee | 24,089 |
| Employee Count | 1,880 |
| Asset Turnover | 1.17 |
| Inventory Turnover | 3.13 |
Taxes
In the past 12 months, BME:ART has paid 7.78 million in taxes.
| Income Tax | 7.78M |
| Effective Tax Rate | 13.88% |
Stock Price Statistics
The stock price has increased by +227.18% in the last 52 weeks. The beta is 0.55, so BME:ART's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +227.18% |
| 50-Day Moving Average | 37.09 |
| 200-Day Moving Average | 25.82 |
| Relative Strength Index (RSI) | 39.90 |
| Average Volume (20 Days) | 30,501 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:ART had revenue of EUR 517.26 million and earned 45.29 million in profits. Earnings per share was 0.79.
| Revenue | 517.26M |
| Gross Profit | 265.91M |
| Operating Income | 64.39M |
| Pretax Income | 56.06M |
| Net Income | 45.29M |
| EBITDA | 76.54M |
| EBIT | 64.39M |
| Earnings Per Share (EPS) | 0.79 |
Balance Sheet
The company has 92.47 million in cash and 142.67 million in debt, with a net cash position of -50.21 million or -0.88 per share.
| Cash & Cash Equivalents | 92.47M |
| Total Debt | 142.67M |
| Net Cash | -50.21M |
| Net Cash Per Share | -0.88 |
| Equity (Book Value) | 120.34M |
| Book Value Per Share | 1.96 |
| Working Capital | 48.92M |
Cash Flow
In the last 12 months, operating cash flow was 51.07 million and capital expenditures -15.04 million, giving a free cash flow of 36.03 million.
| Operating Cash Flow | 51.07M |
| Capital Expenditures | -15.04M |
| Depreciation & Amortization | 12.14M |
| Net Borrowing | -4.32M |
| Free Cash Flow | 36.03M |
| FCF Per Share | 0.63 |
Margins
Gross margin is 51.41%, with operating and profit margins of 12.45% and 8.76%.
| Gross Margin | 51.41% |
| Operating Margin | 12.45% |
| Pretax Margin | 10.84% |
| Profit Margin | 8.76% |
| EBITDA Margin | 14.80% |
| EBIT Margin | 12.45% |
| FCF Margin | 6.97% |
Dividends & Yields
This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 0.49%.
| Dividend Per Share | 0.17 |
| Dividend Yield | 0.49% |
| Dividend Growth (YoY) | 139.81% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 20.83% |
| Buyback Yield | 0.12% |
| Shareholder Yield | 0.61% |
| Earnings Yield | 2.36% |
| FCF Yield | 1.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BME:ART is 29.17, which is -13.44% lower than the current price. The consensus rating is "Buy".
| Price Target | 29.17 |
| Price Target Difference | -13.44% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 14.31% |
| EPS Growth Forecast (3Y) | 24.72% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:ART has an Altman Z-Score of 3.16 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.16 |
| Piotroski F-Score | 6 |